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On distancing and visibility 
Eileen Moyer and Vinh-Kim Nguyen 
A major goal of MAT was to provide a forum for ongoing and emerging debates that 
mobilize the social sciences and humanities to address issues raised by the global expansion 
of biomedical ideas and technologies. As medical anthropologists outside of the United 
States, we were struck by both the dominance of US-based scholarship and its growing 
isolation from a larger pool of engaged thinking that it rarely acknowledged. The lack of 
engagement with scholarship from outside the United States was justified by the prevailing 
assumption that theoretical debate and innovation was unlikely to come from scholars 
whose work was more ‘applied’ and therefore beholden to a dominant biomedical 
epistemology.  
We were acutely aware that most medical anthropology journals were rarely read or even 
known where we work in Africa, Asia, and the Middle East. Most practitioners and activists 
we worked with did not perceive academic medical anthropology to be relevant to their 
struggles. For instance, the paucity of medical anthropology scholarship on the massive 
humanitarian, political, and ecological catastrophe wrought by the ongoing conflict in the 
Middle East is perhaps the most striking – and perhaps not surprising – example, given the 
close relations between powerful US academic anthropologists and US foreign policy and 
international aid institutions. Relatively little attention to the urgent challenges of global 
health efforts, digital firewalls, and at times hermetic prose kept many readers and ‘organic 
intellectuals’ at bay. Producing an open-access, readable, and visually engaging journal, we 
hoped, would help to break down both material and academic walls and promote theorizing 








With this, our seventh issue, it is clear that MAT has indeed become a venue for theoretically 
productive, empirical, and engaged scholarship in and of biomedicine around the globe. This 
issue continues ethnographic engagements with biomedicine and histories of biomedical 
technologies to bring forth strong thematic oppositions that can be glossed as 
visibility/invisibility and distance/intimacy. Perhaps the clearest statement of the stakes 
comes from Cinzia Greco’s discussion of the ethical and epistemological contradictions that 
emerge when ‘activism’ is viewed as antithetical to science: as Greco points out, distancing is 
a way of making invisible. Before returning to these thematic oppositions, we propose to 
briefly frame how anthropologists have constituted biomedicine as an object for empirical 
scrutiny and theoretical production.  
Conceptually, anthropological studies of biomedicine trace their genealogy to E. E. Evans-
Pritchard's seminal study of witchcraft (1937), which demonstrated the rationality of 
witchcraft as a system for managing misfortune, and established a comparative framework 
for the anthropology of medical systems, including biomedicine: the ‘modern’ form of 
medicine that emerged with the rise of the modern state. Several articles in this issue 
complicate a simple narrative that links biomedicine and (European) state formation. A 
powerful alternative narrative emerges from Alexander Friedrich and Stefan Höhne’s 
important theoretical article, translated from the German for this issue’s ‘Found in 
Translation’ section, which argues that a key infrastructure of the biopolitical state is the 
ability to cool, and therefore slow, life itself – what the authors call the Frischeregime. The 
refrigeration of blood, tissues, cells, embryos, and so on equips the invisible, deep 
infrastructure of biomedicine as a regime for managing the very substance of vitality. The 
state–biomedicine nexus is also complicated by Gaurav Datta’s essay, which uses audio 
recordings and photography to document a Catholic HIV clinic for terminally ill patients, a 
regime of pastoral power as yet unarticulated to that of the state. More generally, these 
photos evoke and thereby add to other ethnographic works that examine what happens 
when biomedicine and regimes of clinical care function untethered to a functioning state 
apparatus.  
The theme of visibility is present not only in Datta’s audiovisual essay, but also runs through 
the article by Sara Offersen and colleagues, the reviews of Salmaan Keshavjee’s Blind Spot, 
Francesca Cancelliere’s review of the translation of Hervé Guibert’s important AIDS 
memoir Cytomegalovirus, and Gabriel Girard’s exploration of the traces AIDS has left on 
Montreal’s urban landscape. These concerns with visibility and biomedicine bring us back to 
Michel Foucault’s argument in The Birth of the Clinic. The ‘clinical gaze’, he argued, was 
formed in the nineteenth century with the conjunction of hospital-based medicine, social 
welfare systems that concentrated (largely poor) patients in hospitals, structured observations 
of patients and the lessons discovered at autopsy, and laboratory-based investigations of 
disease states (Foucault [1963] 2003). Foucault’s thesis pointed to the structures of 







intelligibility – what he would later theorize as episteme – that emerge from the clinic and 
constitute it as a centre of authorization. By ‘authorization’ here we refer to practices that 
produce authoritative knowledge, that produce authors of narratives (the subjectivities of 
patients and physicians), and that allow transactions to occur through systems of 
commensurability, as in when blood is extracted and exchanged for knowledge in the form 
of blood tests or clinical trial data. The pieces in this issue point to the work of authorization 
that continues to spill forth from the clinic, embedding itself in subjectivities (Offersen et 
al.), economic regimes (Glabau, Keshavjee), built environments (Borgstrom, Datta, Girard), 
and memories (Cancelliere, Girard). These pieces also contribute to destabilizing the 
assumed continuum between ‘normal’ and ‘pathological’ (Canguilhem 1972) that informs 
biomedical thinking. Structured observations of populations through epidemiological 
research, the growth of a vast pharmaco-therapeutic industry, and biotechnologies were 
added onto the structure of biomedicine resulting in ‘biomedical platforms’ spanning 
laboratories, clinics, and populations. The paper by Offersen and colleagues on the 
potentiality of bodily symptoms shows how the clinical gaze is internalized and experienced 
by ‘ordinary’ Danes, as bodily changes evoke potential future pathologies.  
‘Medicalisation’ refers to the reframing of social problems in medical terms, and the gradual 
processes of normalisation and social control that result (Conrad 1992). More recently, 
‘biomedicalisation’ has been introduced to account for how advances in biomedical 
knowledge about molecular processes and epidemiological outcomes have introduced 
powerful linkages between genes, behaviour, and risk (Clarke et al., 2003). In this view, 
control and normalisation have been replaced by the ways in which individuals govern 
themselves in order to achieve health. Theoretically, these concepts mark a shift from Erving 
Goffman’s sociological theories to those of Foucault, notably his theory of biopower. 
Biopower spans two poles: that of techniques for disciplining the body and that of 
techniques disseminated more broadly through the modern state's attempt to foster healthy 
populations through public policy and infrastructure. Biomedicine stitches these two poles 
together, most tightly in the arena of reproduction and sexuality, but more generally in the 
application of biomedical knowledge to prevention and care. Gaps remain between these 
sutures, as Kim Sue’s investigation into the diagnosis of ‘failure to thrive’ explores. What 
these gaps show, the author argues, is the powerful hold the state continues to have over life 
and death, and how it produces resistances captured and labelled as ‘FTT’. Erica 
Borgstrom’s photo essay on hospices and the ‘#notdingy’ campaign in the United Kingdom 
also captures a moment of resistance, in this case against the assumption that hospice care is 
equivalent to abandonment and decay. 
While the ‘bio’ in ‘biomedicine’ refers to biology as the frame through which health is to be 








government of bodies and populations. Paul Rabinow (1992) introduced the influential 
concept of ‘biosociality’, which initially referred to the emergence of social relations around 
biological self-understanding but has been applied more broadly to highlight biomedical 
forms of social relations. In this vein, notions of biological or biomedical citizenship have 
been used to examine how patient groups make claims on the state, NGOs, and the 
international community, while leaving unquestioned the ‘biological’ as an organizing 
concept (Fassin 2006). More recently, the concept of biocapital has provided an analytical 
framework to account for the growing role of biotechnologies in biomedicine (Rajan 2006). 
‘Biocapital’ therefore refers to the political and economic arrangements that have made it 
possible to manipulate living substances such as cell lines, ova, and genes to produce value, 
notably through the exchange of commodities. The related concept of bioavailability points 
to how populations are made available for harvesting of living substances such as organs for 
transplant (Cohen 2005). Miriam Waltz and Fiona Ross’s examination of the nodes through 
which breast milk is channelled as therapeutic substance, commodity, and gift in a large 
public South African hospital highlights how the circulation of living substances challenges 
moral categories. Maternal milk is unlike cell lines or tissue cultures in that it embodies a 
profoundly intimate relationship, yet here it circulates impersonally, through tubes and 
machines. A similar conundrum exists in the tensions generated by the imperative to prevent 
serious allergic reactions by equipping those with food allergies with expensive devices 
(‘Epipens’) that inject adrenaline in the event of a reaction. This issue shows the power of 
biomedical technologies to confuse distance and intimacy, care and management. 
We are grateful for the quality of the scholarship that continues to be submitted to MAT and 
for the thoughtful and extensive feedback provided by our external peer reviewers. A special 
thanks is reserved for Jenna Grant, who is stepping down as section editor of Book and Film 
Reviews, and we extend a warm welcome to Rita Isabel Henderson from the University of 
Calgary, who joins our team as incoming editor of that section. Finally, we would like to 
acknowledge once again the tremendous support we have received from our host 
institutions, the University of Amsterdam and the Graduate Institute in Geneva.  
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